Technical Analysis for THRD - Third Harmonic Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 11.63 | 0.09% | 0.01 |
THRD closed down 6.74 percent on Wednesday, November 20, 2024, on 89 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.09% | |
| Hammer Candlestick | Bullish | 0.09% | |
| Lower Bollinger Band Walk | Weakness | 0.09% | |
| Wide Bands | Range Expansion | 0.09% | |
| Lower Bollinger Band Touch | Weakness | 0.09% | |
| Slingshot Bearish | Bearish Swing Setup | -6.66% | |
| Bullish Engulfing | Bullish | -6.66% | |
| Crossed Above 200 DMA | Bullish | -6.66% | |
| Lower Bollinger Band Walk | Weakness | -6.66% | |
| Wide Bands | Range Expansion | -6.66% |
| Alert | Time |
|---|---|
| 200 DMA Resistance | about 3 hours ago |
| Up 3% | about 3 hours ago |
| Up 2% | about 3 hours ago |
| Up 1% | about 4 hours ago |
| Down 2 % | about 4 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Immunoglobulin E Mast Cell Chronic Urticaria
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Immunoglobulin E Mast Cell Chronic Urticaria
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.94 |
| 52 Week Low | 7.08 |
| Average Volume | 241,523 |
| 200-Day Moving Average | 12.03 |
| 50-Day Moving Average | 13.30 |
| 20-Day Moving Average | 13.48 |
| 10-Day Moving Average | 13.42 |
| Average True Range | 1.24 |
| RSI (14) | 40.83 |
| ADX | 19.47 |
| +DI | 15.42 |
| -DI | 30.61 |
| Chandelier Exit (Long, 3 ATRs) | 11.78 |
| Chandelier Exit (Short, 3 ATRs) | 13.82 |
| Upper Bollinger Bands | 15.79 |
| Lower Bollinger Band | 11.17 |
| Percent B (%b) | 0.1 |
| BandWidth | 34.24 |
| MACD Line | -0.25 |
| MACD Signal Line | 0.05 |
| MACD Histogram | -0.2945 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.06 | ||||
| Resistance 3 (R3) | 14.93 | 13.66 | 14.48 | ||
| Resistance 2 (R2) | 13.66 | 12.79 | 13.72 | 14.29 | |
| Resistance 1 (R1) | 12.64 | 12.24 | 12.01 | 12.77 | 14.10 |
| Pivot Point | 11.37 | 11.37 | 11.05 | 11.43 | 11.37 |
| Support 1 (S1) | 10.35 | 10.50 | 9.72 | 10.48 | 9.14 |
| Support 2 (S2) | 9.08 | 9.95 | 9.14 | 8.95 | |
| Support 3 (S3) | 8.06 | 9.08 | 8.76 | ||
| Support 4 (S4) | 8.19 |
